Transglutaminase 2-mediated histone monoaminylation and its role in cancer
Bioscience Reports · 28.08.2024 · 44 (8)
DOI: 10.1042/bsr20240493 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 23.08.2024. Verfasst von Huapeng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH 43210, U.S.A. Hauptthemen laut MEDLINE: Protein Glutamine gamma Glutamyltransferase 2, Neoplasms, Protein Processing, Post-Translational, Histones. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Transglutaminase 2 (TGM2) has been known as a well-characterized factor regulating the progression of multiple types of cancer, due to its multifunctional activities and the ubiquitous signaling pathways it is involved in. As a member of the transglutaminase family, TGM2 catalyzes protein post-translational modifications (PTMs), including monoaminylation, amide hydrolysis, cross-linking, etc., through the transamidation of variant glutamine-containing protein substrates. Recent discoveries revealed histone as an important category of TGM2 substrates, thus identifying histone monoaminylation as an emerging epigenetic mark, which is highly enriched in cancer cells and possesses significant regulatory functions of gene transcription. In this review, we will summarize recent advances in TGM2-mediated histone monoaminylation as well as its role in cancer and discuss the key research methodologies to better understand this unique epigenetic mark, thereby shedding light on the therapeutic potential of TGM2 as a druggable target in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH 43210, U.S.A.
- Department of Radiation Oncology, College of Medicine, The Ohio State University, Columbus, OH 43210, U.S.A.
- Center for Cancer Metabolism, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, U.S.A.
- Department of Biological Chemistry and Pharmacology, College of Medicine, The Ohio State University, Columbus, OH 43210, U.S.A.
- Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, IN, U.S.A.
ORCID-Profile: Jinghua Wu, Qingfei Zheng
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Li, H., Wu, J., Zhang, N., & Zheng, Q. (2024). Transglutaminase 2-mediated histone monoaminylation and its role in cancer. Bioscience Reports, 44(8). https://doi.org/10.1042/bsr20240493
Vancouver
Li H, Wu J, Zhang N, Zheng Q. Transglutaminase 2-mediated histone monoaminylation and its role in cancer. Bioscience Reports. 2024;44(8). doi:10.1042/bsr20240493
BibTeX
@article{Li2024,
author = {Li, Huapeng and Wu, Jinghua and Zhang, Nan and Zheng, Qingfei},
title = {Transglutaminase 2-mediated histone monoaminylation and its role in cancer},
journal = {Bioscience Reports},
year = {2024},
volume = {44},
number = {8},
doi = {10.1042/bsr20240493}
}
EUVIMED